Literature DB >> 21518049

Effect of prolonged use of high dose of tibolone on the vagina of ovariectomized rats.

Helene Nara Henriques1, Ana Carolina Bergmann de Carvalho, Porphirio José Soares Filho, José Augusto Soares Pantaleão, Maria Angélica Guzmán-Silva.   

Abstract

The aim of this study was evaluate the effect of prolonged use of high dose of tibolone on the vagina of ovariectomized rats. Bilateral ovariectomy was performed on 14 rats weighing 250 g. Thirty days later, vaginal smears were collected verifying the menopause status by anoestrus cytology. Rats were divided randomly into groups: experimental rats (n = 9) received 1 mg tibolone/day orally and control rats (n = 6) received placebo (carboxymethylcellulose). After 150 days, all rats were sedated and euthanized by cervical displacement. The vagina was removed, fixed in 10% buffered formalin, sampled and processed for paraffin embedding. Histological sections were stained with haematoxylin and eosin, picrosirius red, periodic acid Schiff (PAS) and PAS-diastase, and Weigert's resorcin-fuchsin. Cell proliferation was analysed by immunohistochemistry to detect Ki67. Histomorphometric analyses were performed for epithelial thickness, per cent area of collagen fibres and blood vessels, mast cells and Ki67-positive nuclei per mm of basal membrane. Means and standard error of means were calculated, and data were compared using the Mann-Whitney test, with significance level at P < 0.05. In the vagina, epithelial thickness, number of Ki67-positive nuclei per mm of basal membrane, number of vessels and number of mast cells were significantly higher in the tibolone group when compared with the control group. Furthermore, the content of glycogen and glycoproteins in the vaginal epithelium was modified by tibolone. Tibolone administered in high dose and for a long period has a trophic effect, reversing vaginal atrophy, and has no dysplastic or neoplastic effect in the vagina of ovariectomized rats.
© 2011 The Authors. International Journal of Experimental Pathology © 2011 International Journal of Experimental Pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518049      PMCID: PMC3144515          DOI: 10.1111/j.1365-2613.2011.00774.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  32 in total

1.  Cellular proliferation in the female lower urinary tract with reference to oestrogen status.

Authors:  P J Blakeman; P Hilton; J N Bulmer
Journal:  BJOG       Date:  2001-08       Impact factor: 6.531

2.  Relationship of vaginal cytology to alterations of the vaginal microflora of rats during the estrous cycle.

Authors:  B Larsen; A J Markovetz; R P Galask
Journal:  Appl Environ Microbiol       Date:  1977-03       Impact factor: 4.792

3.  Receptor profiling and endocrine interactions of tibolone.

Authors:  Marcel E de Gooyer; Godefrides H Deckers; Willem G E J Schoonen; Herman A M Verheul; Helenius J Kloosterboer
Journal:  Steroids       Date:  2003-01       Impact factor: 2.668

4.  Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women.

Authors:  Sabina Cauci; Silvia Driussi; Davide De Santo; Paola Penacchioni; Teresa Iannicelli; Paolo Lanzafame; Francesco De Seta; Franco Quadrifoglio; Domenico de Aloysio; Secondo Guaschino
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity.

Authors:  Monica A Pessina; Richard F Hoyt; Irwin Goldstein; Abdulmaged M Traish
Journal:  Endocrinology       Date:  2005-10-06       Impact factor: 4.736

6.  Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Stephen G Swanson; Steven Drosman; Frans A Helmond; Victoria M Stathopoulos
Journal:  Menopause       Date:  2006 Nov-Dec       Impact factor: 2.953

7.  [Effect of high doses of tibolone in body weight and lipid profile of ovariectomized rats].

Authors:  Helene Nara Henriques; Natérsia Rosa Câmara; Ana Carolina Bergmann de Carvalho; José Augusto Soares Pantaleão; Maria Angélica Guzmán-Silva
Journal:  Rev Bras Ginecol Obstet       Date:  2010-02

8.  Plasma nitrate+nitrite levels are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats.

Authors:  R L van Bezooijen; I Que; A G Ederveen; H J Kloosterboer; S E Papapoulos; C W Löwik
Journal:  J Endocrinol       Date:  1998-10       Impact factor: 4.286

9.  Estradiol ameliorates diabetes-induced changes in vaginal structure of db/db mouse model.

Authors:  Tulay T Cushman; Noel Kim; Richard Hoyt; Abdulmaged M Traish
Journal:  J Sex Med       Date:  2009-05-07       Impact factor: 3.802

10.  Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat.

Authors:  Noel N Kim; Miljan Stankovic; Abdullah Armagan; Tulay T Cushman; Irwin Goldstein; Abdulmaged M Traish
Journal:  BMC Womens Health       Date:  2006-09-13       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.